Antibiotic prophylaxis in chemotherapy-induced neutropenia in lung cancer patients

V. Kouranos, A. Vassias, G. Dimopoulos, K. Syrigos (Athens, Greece)

Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients
Session: Palliation and morbidity in lung cancer patients
Session type: Thematic Poster Session
Number: 2772
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Kouranos, A. Vassias, G. Dimopoulos, K. Syrigos (Athens, Greece). Antibiotic prophylaxis in chemotherapy-induced neutropenia in lung cancer patients. Eur Respir J 2011; 38: Suppl. 55, 2772

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Treatment of chemotherapy induced febrile neutropenia in patients with lung and pleural tumours with ertapenem
Source: Eur Respir J 2004; 24: Suppl. 48, 73s
Year: 2004

The effectiveness of pegfilgrastim in preventing leucopenia in patients with lung cancer under chemotherapy
Source: Eur Respir J 2005; 26: Suppl. 49, 77s
Year: 2005

Febrile episodes without leukopenia are more important for survival than febrile leukopenia in lung cancer patients receiving chemotherapy
Source: Eur Respir J 2005; 26: Suppl. 49, 76s
Year: 2005

The incidence of neutropenia in patients undergoing outpatient chemotherapy for lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 755s
Year: 2006

Management of chemotherapy-induced anemia in patients with lung cancer (LC): A comparative study of erythropoietic agents
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012


Neutropenia in lung cancer cases after chemotherapy
Source: Eur Respir J 2006; 28: Suppl. 50, 753s
Year: 2006

Aggressive skin cancers associated with prolonged voriconazole therapy in 4 lung transplant patients
Source: Annual Congress 2009 - Lung transplantation: pre- and postoperative problems
Year: 2009

Chemotherapy induced neutropenia in lung cancer patients: a single centre study
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009

Role of flexible bronchoscopy in the management of patients with febrile neutropenia and lung infiltrates in a cancer setting hospital
Source: International Congress 2019 – Diagnosis of lung cancer
Year: 2019


Evaluation of outpatient infections in lung cancer patients treated with chemotherapy and/or radiotherapy
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Year: 2012

Risk factors of febrile neutropenia induced by chemotherapy in lung cancer patients
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016

Lung cancer patients hospitalized for febrile neutropenia: A retrospective study
Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients
Year: 2010


Significance of febrile episode in patients with lung cancer during therapy - comparison of NSCLC and SCLC patients
Source: Eur Respir J 2002; 20: Suppl. 38, 356s
Year: 2002

Second-line treatment patients at relapse of disseminated small cell lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 395s
Year: 2001

Clinical characteristic of lung cancer patients with interstitial pneumonia treated with chemotherapy or radiotherapy
Source: Annual Congress 2008 - Therapy of thoracic tumours
Year: 2008


Postoperative lung cancer relapse after chemoradiation therapy
Source: International Congress 2014 – Thoracic oncology grand round - an interactive session
Year: 2014



Chronic eosinophilic pneumonia after radiation therapy for breast cancer
Source: Eur Respir J 2004; 23: 9-13
Year: 2004



Chronic eosinophilic pneumonia after radiation therapy for breast cancer
Source: Annual Congress 2011 - Rare diffuse lung diseases
Year: 2011

Efficacy of darbepoietin alfa in anemia developed during chemotherapy for lung cancer
Source: Annual Congress 2008 - Treatment of thoracic tumours
Year: 2008